Form 4 holding
COO & GC
Structure Therapeutics Inc.
- Security class
- Ordinary Shares
- Shares / value
- 184,614
- Estimated value
- $8,898,394
- Report date
- 15 Apr 2026
- Price
- $48.20
- Ownership
- Direct
Matthew Lang - COO & GC at Structure Therapeutics Inc.
Issuer-level insider activity
- Role
- Coo & Gc
- Issuer ticker
- GPCR on Nasdaq
- Entity type
- Individual
- Source filing history
- Open source filing history
Identity
Names, identifiers, and filing context for this profile.
1 identity field
Source evidence
Original filing metadata and source links for verification.
1 source field
No buys or sells have been reported by Matthew Lang since 20 Sep 2025
Reported holdings for Matthew Lang in Structure Therapeutics Inc.
Form 4 holding
COO & GC
Structure Therapeutics Inc.
- Security class
- Share option (right to buy)
- Shares / value
- 223,776
- Estimated value
- Report date
- 15 Apr 2026
- Price
- Ownership
- Direct
- Underlying class
- Ordinary Shares
- Underlying amount
Transaction history for Matthew Lang in Structure Therapeutics Inc.
| Sym | Class | Transaction | % | SEC-reported value | SEC-reported price | Shares | Shares after | Date | Ownership |
|---|
* marks a reported price that did not pass the local price check.